Physician profile
John F Hall
NPI 1174533723
$782,869.84
in general payments reported to CMS, 2019-2025
21 companies · $126K in 2025
The $126K reported for 2025 was more than what 94% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228K · 2020: $125K · 2021: $147K · 2022: $111K · 2023: $41K · 2024: $5,492 · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $154K · Travel and Lodging: $15K · Food and Beverage: $2,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $153,650.43 |
| Travel and Lodging | $15,114.61 |
| Food and Beverage | $2,917.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $381,409.67 | 2019-2025 | Prodisc L, Prodisc C, Prodisc C Vivo |
| Depuy Synthes Products, INC. | $230,277.14 | 2019-2022 | |
| Medical Device Business Services, INC. | $147,723.74 | 2019-2023 | Synfix Evolution |
| Alphatec Spine, INC | $9,391.09 | 2022-2025 | Other - Miscellaneous, Solus Alif |
| Pacira Pharmaceuticals Incorporated | $6,930.00 | 2021-2022 | |
| Depuy Synthes Sales INC. | $2,434.11 | 2019-2023 | Acis |
| Nuvasive, INC. | $1,410.86 | 2021-2022 | |
| Seaspine Orthopedics Corporation | $689.20 | 2022 | |
| Brainlab, INC. | $677.32 | 2019-2020 | |
| Alevio, LLC | $634.28 | 2020-2023 | Sicure Sacroiliac Joint Fusion System |
| Cerapedics INC. | $306.36 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Lifenet Health | $247.63 | 2023 | |
| Sanara Medtech INC. | $178.28 | 2024 | Celleraterx |
| Medtronic, INC. | $150.16 | 2022 | |
| Providence Medical Technology, INC. | $137.20 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $84.59 | 2024 | |
| Globus Medical, INC. | $80.72 | 2022 | |
| Orthofix Medical, INC. | $46.86 | 2020-2025 | Cervical-Stim |
| Nalu Medical, INC. | $31.77 | 2024 | Nalu Neurostimulation System |
| Kuros Biosciences USA, INC | $14.79 | 2025 | Magnetos |
| Pfizer INC. | $14.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.